HECTD3 and cardiac hypertrophy: Consistent with the in vitro findings, overexpression of HectD3 in mouse hearts inhibited cardiac hypertrophy and moderately improved cardiac function compared to control AAV-injected mice after TAC (Fig. 5g–i).